What was Xcelerate’s price range in the past 12 months?
Xcelerate lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Xcelerate’s market cap?
Xcelerate’s market cap is $9.50M.
When is Xcelerate’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Xcelerate overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Xcelerate pay dividends?
Xcelerate does not currently pay dividends.
What is Xcelerate’s EPS estimate?
Xcelerate’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xcelerate have?
Xcelerate has 434,446,080 shares outstanding.
Which hedge fund is a major shareholder of Xcelerate?
Currently, no hedge funds are holding shares in XCRT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Xcelerate
Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents, which it then applies to nascent medical technology ventures. The firm's offerings are subsequently deployed within regulated clinical settings for rigorous evaluation, validation, and real-world implementation. Beyond this, the company oversees a comprehensive, full-spectrum approach to medical technology creation and deployment. Established in 1996, the Mauldin, South Carolina-based entity was previously known as Union Dental Holdings, Inc. before rebranding as Xcelerate Inc.